BNTX
Price
$102.53
Change
-$2.11 (-2.02%)
Updated
Sep 25, 2:06 PM EST
42 days until earnings call
NVAX
Price
$7.04
Change
-$0.09 (-1.26%)
Updated
Sep 25, 10:14 AM EST
38 days until earnings call

Compare trend and price BNTX vs NVAX

Header iconBNTX vs NVAX Comparison
Open Charts BNTX vs NVAXBanner chart's image
BioNTech SE American Depositary Share
Price$102.53
Change-$2.11 (-2.02%)
Volume$100
CapitalizationN/A
Novavax
Price$7.04
Change-$0.09 (-1.26%)
Volume$1.88K
CapitalizationN/A
View a ticker or compare two or three
BNTX vs NVAX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
BNTX vs. NVAX commentary
Sep 25, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTX is a StrongSell and NVAX is a Hold.

COMPARISON
Comparison
Sep 25, 2023
Stock price -- (BNTX: $104.64 vs. NVAX: $7.13)
Brand notoriety: BNTX: Not notable vs. NVAX: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNTX: 64% vs. NVAX: 66%
Market capitalization -- BNTX: $25.09B vs. NVAX: $719.45M
BNTX [@Biotechnology] is valued at $25.09B. NVAX’s [@Biotechnology] market capitalization is $719.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $410.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNTX’s FA Score shows that 2 FA rating(s) are green whileNVAX’s FA Score has 0 green FA rating(s).

  • BNTX’s FA Score: 2 green, 3 red.
  • NVAX’s FA Score: 0 green, 5 red.
According to our system of comparison, BNTX is a better buy in the long-term than NVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNTX’s TA Score shows that 5 TA indicator(s) are bullish while NVAX’s TA Score has 3 bullish TA indicator(s).

  • BNTX’s TA Score: 5 bullish, 5 bearish.
  • NVAX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BNTX is a better buy in the short-term than NVAX.

Price Growth

BNTX (@Biotechnology) experienced а -7.45% price change this week, while NVAX (@Biotechnology) price change was -7.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.05%. For the same industry, the average monthly price growth was +21.89%, and the average quarterly price growth was +34.13%.

Reported Earning Dates

BNTX is expected to report earnings on Nov 06, 2023.

NVAX is expected to report earnings on Nov 02, 2023.

Industries' Descriptions

@Biotechnology (-3.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BNTX with price predictions.
OPEN
A.I.dvisor published
a Summary for NVAX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BNTX($25.1B) has a higher market cap than NVAX($719M). BNTX (-30.342) and NVAX (-30.642) have similar YTD gains . BNTX has higher annual earnings (EBITDA): 6.05B vs. NVAX (-534.62M). BNTX has more cash in the bank: 15.6B vs. NVAX (506M). NVAX (199M) and BNTX (206M) have identical debt. BNTX has higher revenues than NVAX: BNTX (9.18B) vs NVAX (1.6B).
BNTXNVAXBNTX / NVAX
Capitalization25.1B719M3,491%
EBITDA6.05B-534.62M-1,131%
Gain YTD-30.342-30.64299%
P/E Ratio5.44N/A-
Revenue9.18B1.6B575%
Total Cash15.6B506M3,083%
Total Debt206M199M104%
FUNDAMENTALS RATINGS
NVAX: Fundamental Ratings
NVAX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BNTXNVAX
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 21 days ago
82%
Bullish Trend 20 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
80%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NWHVX12.320.02
+0.16%
Nationwide Geneva Mid Cap Gr A
ACERX9.69-0.02
-0.21%
Invesco Equity and Income C
MDBAX17.23-0.04
-0.23%
BlackRock Large Cap Focus Value Inv A
CUHAX9.35-0.03
-0.32%
Victory US 500 Enh Vol Wtd Idx A
ARYEX21.97-0.15
-0.68%
American Century Real Estate Y

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been closely correlated with MRNA. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if BNTX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
-1.68%
MRNA - BNTX
75%
Closely correlated
-0.24%
AXON - BNTX
43%
Loosely correlated
-0.36%
SRNEQ - BNTX
37%
Loosely correlated
-2.54%
FGEN - BNTX
33%
Loosely correlated
-6.50%
GMAB - BNTX
33%
Poorly correlated
-1.12%
More